Back to search

Bridge To Life (Europe) Ltd

08072237

active
Private Limited Company
england wales
Companies House
Health Score
68 / 100

Some Concerns

30/30
Filing
0/30
Financial
38/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)
  • 1 outstanding charge (-2)

Details

LU 311 THE LIGHT BULB, LONDON, SW18 4GQ
Incorporated 16/05/2012

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 16/05/2026

Due 30/05/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Stevan Schweighardt

director · Since 16/05/2012

DIRECTOR OF MEDICAL DEVICE COMPANY

AMERICAN · UNITED STATES · Age 82

Persons with Significant Control

Ceo Stevan Schweighardt

25–50% shares

American · United States · Age 82

Lu 311 The Light Bulb, 1 Filament Walk, London, SW18 4GQ

Notified 01/07/2016

Charges1 outstanding

Charge
outstanding

PERCEPTIVE CREDIT HOLDINGS III, LP

Created 09/08/2021Registered 18/08/2021
Charge
satisfied

LLOYDS BANK PLC

Created 05/08/2020Registered 05/08/2020Satisfied 11/07/2021

CompanyRankvs 1686+ SIC 72110 peers
31

Financial strength6th percentile among SIC peers · 2/25
Employees94th percentile among SIC peers · 14/15
LiquidityCurrent ratio 0.95× · 6/20
Longevity14 years trading (max 15) · 14/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
1686Bridge To Life (Europe) Ltd
47
How is this score calculated?
Financial strength2/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity14/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

an event that would cast significant doubt on the Company's ability to continue trading as a going concern and therefore gives rise to material uncertainty. Page 2 BRIDGE TO LIFE (EUROPE) LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 2. Accounting policies (continued) 2.3 F

Key FinancialsYear ending 31/12/2024

Net Worth

-£243k

Balance sheet strength

Cash

£363k

Cash in the bank

Net Current Assets

-£243k

Working capital

Current Assets

£4.5M

Current Liabilities

£4.8M

Debtors

£1.4M

14avg. employees

Tax at Year End(2019)

Corp tax£74

Balance Sheet

Assets less current liabilities-£243k
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20240.95+£135k
20230.94+£92k
20220.96+£134k
20210.90+£94k
20200.74-£976k
20191.04—

Derived from filed accounts. Not audited figures.